N
SDEV
vs
S&P 500
S&P 500
Over the past 12 months, SDEV has underperformed S&P 500, delivering a return of -63% compared to S&P 500's +19% growth.
Stocks Performance
SDEV vs S&P 500
Performance Gap
SDEV vs S&P 500
Performance By Year
SDEV vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
NovaBay Pharmaceuticals Inc
Glance View
NovaBay Pharmaceuticals is a healthcare company that develops and sells products for eye care and skin care, with a focus on antimicrobial and hygiene-based treatments. Its best-known products are sold through doctors, pharmacies, and other healthcare channels, and they are aimed at everyday problems such as eyelid cleaning, irritation, and wound or skin hygiene. The company makes money by selling these products to distributors, clinics, pharmacies, and consumers, depending on the product and channel. In simple terms, it sits between drug development and consumer healthcare: it creates branded medical products, then earns revenue when those products are bought and used in the market. What makes NovaBay different is that it is not a broad drugmaker with a large pipeline of prescription medicines. Instead, it focuses on a narrower set of specialty products that are easier to understand and often used as part of routine care. That gives it a business tied to recurring everyday healthcare needs rather than one-time treatments.
